Connect with us
European Gaming Congress 2024

Artificial Intelligence

Outpace Bio, a Leader in Protein Design & Cell Engineering, Adds Bahija Jallal to Board of Directors

Published

on

<!– Name:DistributionId Value:8793978 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:4573 –> <!– Name:CustomerId Value:1270017 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:9a597f83-589f-42ec-bd17-ad6630e230a1 –>

Seattle, WA, March 23, 2023 (GLOBE NEWSWIRE) — Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies, today announced that Dr. Bahija Jallal has joined its Board of Directors. The move bolsters Outpace’s efforts to develop technologies that can reprogram how gene-modified cell therapies function and coordinate a productive immune response, yielding safe and effective cell therapies for cancer patients.

Bahija Jallal, CEO and Director of the Board of Immunocore, a commercial-stage biotechnology company oversaw the historic regulatory approval of the world’s first T cell receptor (TCR) therapy for a solid tumor. She brings deep R&D and company leadership experience to Outpace.

As President of MedImmune and Executive Vice President of AstraZeneca, Jallal led the development and approval of five new biologic medicines across three therapeutic areas, while boosting the company’s research & development pipeline and deal-making. Dr. Jallal serves on the Board of Elevance, Inc. and is a member of the Board of Trustees of Johns Hopkins University and the Board of Directors of the University of Maryland Health Sciences Research Park Corporation. She is a member of the National Science Foundation and a past President of the board of the Association of Women in Science. The Healthcare Businesswomen’s Association named her its 2017 Woman of the Year.

“The Outpace team has potentially cracked the code by creating entirely new protein functions from scratch,” said Jallal. “Outpace is reimagining how biology should function, and I am pleased to work with a company that has an opportunity to transform the future of cell therapy.”

Advertisement

Matt Hershenson, a founding General Partner at deep-tech venture capital firm Playground Global, has also joined Outpace’s Board of Directors. With a track record of founding a startup that achieved >$50M Annual Recurring Revenue and was later acquired by Microsoft for $500M, along with years of experience building leading engineering teams at Apple, Microsoft, and Google, Hershenson brings an exceptional ability to guide the development of world-changing technologies.

In 2021, Outpace raised a $55 million Series A composed of an initial $30 million Series A round and a follow-on $25 million Series A-1 extension. Existing investor Playground Global led the extension financing, with participation from new investor Bristol Myers Squibb and returning investors ARTIS Ventures (a TechBio-focused investor), Mubadala Capital (the asset management arm of Mubadala Investment Company), Sahsen Ventures, and Civilization Ventures.

The Series A funding has enabled Outpace to establish its cell programming platform and its partnership approach to development. The Series A-1 extension funding will accelerate development of the Company’s OutLast™ autonomous regulation and OutSmart™ controlled cytokine technologies, geared toward increasing the ability of engineered T cells to persist in the body and to recruit endogenous immune cells for a more productive anticancer response.

Additionally, Outpace is using the funding to build out an internal pipeline focused on anticancer T cell therapies with dramatically enhanced efficacy by leveraging its OutLast™ and OutSmart™ technologies. These new efforts complement the Company’s partnership model, allowing Outpace to develop technologies using internal assets and to deploy them through partnerships across modalities and applications.

“Our bodies inherently make the wrong decisions when fighting cancer,” said Marc Lajoie, CEO and co-founder of Outpace. “We aim to cure cancer and other diseases by developing cell therapy products that make better decisions inside patients, improving persistence, immune engagement, and safety. With Bahija Jallal and Matt Hershenson on the Board, our ambition is to accelerate the development of our unique technologies and open new collaborations with world-leading partners to create curative cell and gene therapies.”

Advertisement

About Outpace Bio
Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that overcome the barriers to efficacy and safety by programming cells to make the right decisions inside patients. Outpace’s suite of technologies drive persistent activity of the cell therapy (OutLast™), recruit a productive immune response in the tumor microenvironment (OutSmart™), and achieve the potency (OutSpacers™), specificity (Co-LOCKR™), and safety (EGFRopt™) necessary to unlock diverse cancer indications. Outpace’s internal and partnered pipeline approach is optimized for rapid clinical validation of its technologies across diverse cell types and manufacturing processes. Outpace is based in Seattle, Washington. To learn more, visit outpacebio.com or email [email protected] and follow on Twitter and Instagram @OutpaceBio.

About ARTIS Ventures
ARTIS Ventures (AV) partners with entrepreneurs who are driven to impact the world by reshaping and reinventing industries. The team supports its portfolio companies through their entire life-cycle, from initial venture investment to public offering and beyond. As an early leader in the emerging TechBio sector, ARTIS Ventures funds companies at the intersection of computer science and life science, applying engineering principles and data-enabled discovery to the healthcare space. Notable companies the firm has backed include Stemcentrx, Outpace Bio, Tessera Therapeutics, Freenome, Eko, Delix, Modern Meadow, Excision BioTherapeutics, Lemonaid Health, and more. For more information visit www.av.co or email [email protected].

About Playground Global
Playground Global invests in founders harnessing frontier technologies to build transformational businesses with multi-generational impact. Recognizing the promise in early stage entrepreneurs developing new solutions in artificial intelligence, automation, life sciences, next-gen compute, cybersecurity, aerospace, and beyond, Playground offers world-class expertise across a wide variety of business and technical domains to help companies achieve their potential. Learn more at playground.global.

#


Advertisement

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

VeriPark Receives Microsoft Business Applications 2024/2025 Inner Circle Award and Joins Partner Advisory Council

Published

on

veripark-receives-microsoft-business-applications-2024/2025-inner-circle-award-and-joins-partner-advisory-council

LONDON, Sept. 23, 2024 /PRNewswire/ — VeriPark, a Microsoft Solutions Partner in the Financial Services Industry, has been selected for the Business Applications 2024-2025 Microsoft Inner Circle and the Microsoft Financial Services Partner Advisory Council.

Participation within Inner Circle is based on sales achievements that rank VeriPark in the top echelon of Microsoft’s Business Applications global network of partners. Inner Circle members are known for performing at a high-level by delivering innovative solutions that help organizations excel.
Ozkan Erener, CEO VeriPark: “We are honored to once again be recognized by Microsoft for our commitment to driving digital transformation for our clients. Partnering closely with Microsoft allows us to harness the latest technologies to revolutionize the Financial Services Industry. This recognition highlights the success of our collaborative strategy and execution.”
VeriPark first joined Microsoft’s Inner Circle in 2011 and has since provided innovative solutions that help financial institutions achieve a competitive advantage. By leveraging Microsoft’s platform, VeriPark continues to offer unparalleled services and solutions to its clients.
“Partners achieving the Inner Circle demonstrate an exceptional impact helping customers accelerate their AI and digital transformation with Dynamics 365 and Power Platform,” said Peter Jensen, Microsoft Business Application Partner Strategy Lead. “Microsoft AI Cloud Partner Program partners who achieve the Business Application Inner Circle distinction stand out for their deep AI, Cloud and Industry knowledge.”
Additionally, VeriPark’s selection for the Financial Services Partner Advisory Council highlights its role in shaping Microsoft’s financial services strategies and product roadmaps. As a PAC member, VeriPark will provide feedback on Microsoft’s financial services solutions and gain early insights into future roadmaps.
About VeriPark 
VeriPark is a global solutions provider enabling financial institutions to become digital leaders by placing Customer Experience at the core of digital transformation. VeriPark’s Intelligent Customer Experience suite delivers world class customer journeys on digital and assisted channels.
With its main offices located in the United Kingdom, Europe, North America, Asia, Africa and the Middle East, VeriPark helps financial institutions to enhance customer acquisition, retention and cross-sell capabilities. Their proven, secure, and scalable solutions cover Customer Engagement, Omni-Channel Delivery, Branch Automation, and Loan Origination. VeriPark collaborates with clients, crafting innovative technology strategies and solutions, that impact millions of people daily, bringing the promise of digital transformation to life.
Logo – https://mma.prnewswire.com/media/2447880/VeriPark_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/veripark-receives-microsoft-business-applications-20242025-inner-circle-award-and-joins-partner-advisory-council-302253197.html

Continue Reading

Artificial Intelligence

PolyAI partners with OpenTable to offer enterprise restaurants and diners reservation support using voice AI

Published

on

polyai-partners-with-opentable-to-offer-enterprise-restaurants-and-diners-reservation-support-using-voice-ai

LONDON and NEW YORK, Sept. 23, 2024 /PRNewswire/ — PolyAI, a pioneer in voice AI solutions for customer experience and service, today announced a partnership with OpenTable, a global leader in restaurant technology, expanding PolyAI’s guest-led voice assistants to enterprise restaurants. Locations that opt in will be able to take reservations over the phone, answer questions, gain visibility in customer trends, and deliver on-brand experiences – all while alleviating staff time and resources.

This alliance delivers PolyAI’s lifelike voice AI to help restaurants tackle challenges around staffing and provide consistent hospitality, even off premise. In a survey conducted by the National Restaurant Association, 62% of operators said their restaurants did not have enough employees to support existing demand. With onsite staff focused on in-house patrons, restaurant groups routinely miss between 30-60% of phone calls to their front of house (per PolyAI customer data) – meaning missed revenue opportunities and equally valuable customer touch points.
Never miss another call, thanks to PolyAI and OpenTable
With this strategic partnership, OpenTable’s global network of restaurants will be able to integrate PolyAI voice assistants, built using generative AI and spoken language technologies, to assist their diners in seamlessly booking and managing reservations over the phone, during and outside of operating hours.
“We know how tightly restaurants manage their guest experience and this can be even more complex for our partners doing business at scale,” said Susan Lee, Chief Strategy Officer at OpenTable. “We have, and continue to invest in, technology that pushes boundaries and enhances hospitality and our integration with PolyAI is a new way we can drive efficiencies for our restaurants, and diners.”
For larger operators, this partnership enables numerous iterations of voice assistants to cater to the unique needs of multi-location and multi-brand portfolios, while providing PolyAI’s proven enterprise-grade assurances around availability, security and data protection.
“We have extensive experience deploying voice assistants to hundreds of locations for some of the largest restaurant groups in the world, helping operators resolve up to 70% of calls over the phone without the need for additional staff,” said Michael Chen, VP of Strategic Alliances at PolyAI. “This strong connection with the restaurant industry started right from the earliest days of PolyAI. We’re thrilled to deepen that further and work with OpenTable to help even more restaurant operators attract more diners, streamline operations and maximise revenue.”
The journey starts at the Integration Marketplace
OpenTable restaurants will be able to request an integration with PolyAI via its Integration Marketplace, which powers 150+ integrations among the most widely used restaurant software. Beyond managing reservations over the phone, PolyAI’s guest-led voice assistants also offer operators a powerful new channel for implementing consistent brand experiences that can deliver greater personalisation, more proactive revenue and upsell as well as offer new ways of collecting diner feedback and tracking customer satisfaction.
About PolyAI
PolyAI is a leading provider of AI-powered voice assistants. Their customer-led voice assistants are used across industries within global companies where B2C conversations are crucial, like Whitbread, Greene King, Caesars Entertainment and FedEx. PolyAI’s award-winning voice assistants have earned renown for their ability to understand natural language and provide quick, accurate and helpful responses. Hear more about what they’re bringing to the market by visiting poly.ai
About OpenTable
OpenTable, a global leader in restaurant tech and part of Booking Holdings, Inc. (NASDAQ:BKNG), helps more than 60,000 restaurants worldwide fill 1.7 billion seats a year.  OpenTable’s world-class technology empowers restaurants to focus on what matters most – their team, their guests, and their bottom line – while enabling diners to discover and book the perfect restaurant for every occasion.
Logo – https://mma.prnewswire.com/media/1893052/PolyAI_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/polyai-partners-with-opentable-to-offer-enterprise-restaurants-and-diners-reservation-support-using-voice-ai-302254622.html

Continue Reading

Artificial Intelligence

Clarivate and Relatable Healthcare Forge Strategic Partnership to Transform Medtech Sales Contracting Process

Published

on

clarivate-and-relatable-healthcare-forge-strategic-partnership-to-transform-medtech-sales-contracting-process

Clarivate Medtech Intelligence and Relatable software enhance product data management and competitive conversion efficiency for medtech sales, contracting and pricing teams
LONDON, Sept. 23, 2024 /PRNewswire/ — Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced a strategic partnership with Relatable Healthcare, a technology company delivering Product Relationship Management (PRM) software to leading medtech companies to drive revenue and workflow efficiency.

Relatable™ is a Product Relationship Management (PRM) platform created for medtech manufacturers and distributors to unlock new competitive conversion capabilities that drive cost-efficient revenue growth. The platform establishes a single source of truth for all information associated with specific products and their direct competitors, populating a data management platform available to contracting, sales, marketing and technical support teams.
Within the Relatable™ platform, customers can now access comprehensive competitive intelligence from Clarivate in addition to product specifications and cross-references, inventory availability, sales collateral, EPP data, chemicals of concern, manufacturing origin, or any custom proprietary data a customer wishes to manage.  This partnership empowers Clarivate and Relatable clients to make confident strategic pricing decisions, streamline sales contracting processes, and enhance contract compliance by offering comprehensive tools and insights to manage the entire contracting cycle effectively. 
Andrew Lee, Vice President Medtech, Life Sciences & Healthcare, Clarivate, said: “At Clarivate, we are focused on expanding our market intelligence and data analytics offering in the medical device and technology sectors while providing powerful workflow solutions that turn data-driven insights into decisions and actions that accelerate growth for our clients. This new strategic partnership enables us to support the industry in getting products to patients faster.”
Joshua Emert, CEO of Relatable Healthcare, said: “At Relatable Healthcare, we are dedicated to creating intuitive software that modernizes how innovative medical device and supply companies leverage product intelligence to drive efficient revenue growth. We are excited to partner with Clarivate and its medtech customers to automate workflows across contracting, sales, marketing and product support. This will enable instant cross-referencing of competitive products in RFP responses, more frequent measurement of contract compliance and proactive discovery of conversion opportunities in the field.”
In an evolving healthcare landscape, medical device and supply companies, along with their distributors, face significant challenges in communicating their product value and offering consultative insights. They also struggle with driving adoption and analyzing market trends effectively. Cost-constrained healthcare providers rigorously evaluate purchasing decisions, comparing devices and supplies in detail. To meet this demand, medtech companies require up-to-date competitive intelligence and advanced software to analyze and communicate tailored portfolio insights for each contracting, sales and conversion opportunity.
This collaboration enables medtech companies to commercialize products and serve Integrated Delivery Networks (IDNs), Group Purchasing Organizations (GPOs), health systems and independent hospitals, surgery centers and clinics, streamlining the entire revenue growth process more efficiently. Combining the deep product-level market knowledge of Clarivate with enterprise software by Relatable Healthcare equips medtech companies with the insights and tools to win new business and drive contract compliance.
About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com
About Relatable Healthcare
Relatable Healthcare is a technology company delivering pioneering Product Relationship Management (PRM) solutions for the medical device and supply industry. Our data management tools and automated workflows help leading MedTech organizations drive efficient revenue growth across the commercialization spectrum. For more information, please visit www.relatable.io
Media Contact:Luna Ivkovic,External Communications, Life Sciences & [email protected] 
Logo – https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/clarivate-and-relatable-healthcare-forge-strategic-partnership-to-transform-medtech-sales-contracting-process-302253772.html

Continue Reading
Advertisement
Advertisement

Latest News

Trending